Third CAR-T gets TGA tick

By Megan Brodie 3 years ago | In Cell and gene therapies
  • 3 years ago

6 August 2021 Gilead’s second CAR-T cell therapy TECARTUS (brexucabtagene autoleucel) has gained TGA approval…

This is subscriber-only content. Please login to continue reading.